731 related articles for article (PubMed ID: 26751860)
1. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
2. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes.
Millecamps S; Boillée S; Le Ber I; Seilhean D; Teyssou E; Giraudeau M; Moigneu C; Vandenberghe N; Danel-Brunaud V; Corcia P; Pradat PF; Le Forestier N; Lacomblez L; Bruneteau G; Camu W; Brice A; Cazeneuve C; Leguern E; Meininger V; Salachas F
J Med Genet; 2012 Apr; 49(4):258-63. PubMed ID: 22499346
[TBL] [Abstract][Full Text] [Related]
3. Als and Ftd: Insights into the disease mechanisms and therapeutic targets.
Liscic RM
Eur J Pharmacol; 2017 Dec; 817():2-6. PubMed ID: 29031901
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R; Neumann M
Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of amyotrophic lateral sclerosis.
Liscic RM; Breljak D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):370-2. PubMed ID: 20655970
[TBL] [Abstract][Full Text] [Related]
6. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol.
Kalmar B; Lu CH; Greensmith L
Pharmacol Ther; 2014 Jan; 141(1):40-54. PubMed ID: 23978556
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.
Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ
Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541
[TBL] [Abstract][Full Text] [Related]
8. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
Verma A
Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
[TBL] [Abstract][Full Text] [Related]
9. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
10. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update.
Lattante S; Rouleau GA; Kabashi E
Hum Mutat; 2013 Jun; 34(6):812-26. PubMed ID: 23559573
[TBL] [Abstract][Full Text] [Related]
11. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
12. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
Neumann M
Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
[TBL] [Abstract][Full Text] [Related]
13. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
14. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
15. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Zou ZY; Zhou ZR; Che CH; Liu CY; He RL; Huang HP
J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):540-549. PubMed ID: 28057713
[TBL] [Abstract][Full Text] [Related]
16. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
17. Rapid in vitro quantification of TDP-43 and FUS mislocalisation for screening of gene variants implicated in frontotemporal dementia and amyotrophic lateral sclerosis.
Oyston LJ; Ubiparipovic S; Fitzpatrick L; Hallupp M; Boccanfuso LM; Kwok JB; Dobson-Stone C
Sci Rep; 2021 Jul; 11(1):14881. PubMed ID: 34290285
[TBL] [Abstract][Full Text] [Related]
18. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
Wang XN; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
[TBL] [Abstract][Full Text] [Related]
19. [Genetic architecture of amyotrophic lateral sclerosis and frontotemporal dementia : Overlap and differences].
Synofzik M; Otto M; Ludolph A; Weishaupt JH
Nervenarzt; 2017 Jul; 88(7):728-735. PubMed ID: 28573364
[TBL] [Abstract][Full Text] [Related]
20. Targeted next-generation sequencing study in familial ALS-FTD Portuguese patients negative for C9orf72 HRE.
Gromicho M; Coutinho AM; Pronto-Laborinho AC; Raposeiro R; Tavares J; Antunes D; de Carvalho M
J Neurol; 2020 Dec; 267(12):3578-3592. PubMed ID: 32638105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
